Mesenchymal stem cell differentiation into osteoblast, chondrocyte, and adipocyte lineages (MSC differentiation (osteoblast/chondrocyte/adipocyte))

The phrase "Tissue repair/regeneration via differentiation into osteoblasts/chondrocytes/adipocytes" refers to the biological process by which mesenchymal stem cells (MSCs) differentiate into three major lineages—osteoblasts (bone-forming cells), chondrocytes (cartilage-forming cells), and adipocytes (fat-storing cells). This process underlies tissue homeostasis and regeneration in bone marrow and other tissues. The balance between these fates is tightly regulated by transcription factors such as Runx2 for osteogenesis and PPARγ for adipogenesis[3][1]. Multiple signaling pathways—including Wnt/β-catenin, Hedgehog, BMPs—govern this balance[3]. Dysregulation can contribute to diseases like osteoporosis or obesity. However, this entry does not refer to a specific molecular target but rather describes a cellular program involving multiple genes and pathways[1][4]. Therefore it should not be considered a canonical therapeutic target. This entry is best classified as an umbrella term describing cellular plasticity rather than an individual molecule/receptor/enzyme. For structured data purposes it should be flagged as incorrect/not specific enough.

Other names

MSC lineage commitmentMesenchymal stromal cell differentiationMultipotent mesenchymal progenitor differentiation